The company sees a demand for customized individual packaging solutions as the pharmaceutical manufacturing industry moves towards smaller lot sizes that require aspects of individualization.
Pharmaceutical packaging company, August Faller will be presenting products and services for individualized and personalized packaging solutions at CPhI 2016. Exhibiting at the show for the sixth time, August Faller’s portfolio includes the standard folding carton, special designs for clinical trials, special labels, and packaging services for small to mid-sized amounts.
August Faller sees a demand for customized individual packaging solutions as pharmaceutical manufacturing activities move towards smaller lot sizes that require aspects of individualization. The company believes this trend is driven by the increasing number of orphan drugs and companion diagnostics products with which tests are offered together with medications. Higher patient expectations also drive the need for individualised packaging units, shorter development times, and cost-effective clinical test series.
One of August Faller’s packaging solutions and services is the manufacture of high-quality labels using a digital printing process. The camera inspection systems ensure 100% monitoring of the process.
In addition to standard packaging, Faller also makes customized designs for clinical trials or designs for medications for rare illnesses-for example packaging with inner partitions to protect against breakage, labels for documentation in the patient records, or wallets for tablets or capsules.
As a system supplier, August Faller also offers packaging services such as packaging and manual packaging of medications for clinical studies at its PharmaServiceCenter at the Großbeeren location.
Managing partner of August Faller GmbH & Co. KG, Dr. Daniel Keesman, will also be giving a presentation on the topic of “Managing the challenging complexity of printed packaging material in the digital age” on the first day of the exhibition.
Source: August Faller, Stand 2H30
WMFTS’ BioPure to Showcase Single-Use Bioclamp with Refined Manufacturing at INTERPHEX 2025
April 1st 2025With advanced manufacturing, BioPure’s BioClamp connector is manufactured to be 13% lighter than the previous model, resulting in a 26% reduction in carbon dioxide emissions across the full lifecycle of the product.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.